Formation Bio
Formation Bio acquires clinical-stage drugs from pharma, universities, and biotech and develops them faster and more efficiently by leveraging our proprietary tech-driven drug development platform.
undefined | Careers - formation.bio
At Formation Bio, we believe that our people, values, and culture serve as a great competitive advantage. We harness the collective expertise of professionals hailing from various industries to fast-track innovative treatments for a healthier future. Join us …
undefined | About Us - formation.bio
At Formation Bio we believe bringing together diverse people from different industries will allow us to achieve this. We are a team of tech and pharma experts who deeply believe in this mission and are excited to make a difference in the industry by bringing new treatments to patients faster and more efficiently.
undefined | Introducing Formation Bio
2023年12月5日 · Formation Bio is setting a new standard for the pace of drug development. We're a tech-driven pharma company, bringing together technical depth, pharma acumen, and an enterprising spirit to shave years off the time it takes to bring new treatments to patients safely.
undefined | Licensing & Pipeline - formation.bio
At Formation Bio we create more value per drug program by leveraging our proprietary platform to develop promising drug candidates. Our core competencies include: Faster drug development through proprietary tech-driven platform
undefined | Our Model - formation.bio
Formation Bio is an end-to-end drug developer that leverages its proprietary tech-driven platform to develop drugs faster and more efficiently, unlocking greater value per program and accelerating access to new treatments for patients.
undefined | Technology - formation.bio
At Formation Bio, we are focused on scaling drug development with technology and AI, rather than with humans. Our technology platform integrates into all core aspects of the drug development lifecycle, providing meaningful insights that …
undefined | Contact - formation.bio
For press or other corporate inquiries, please reach out via email.
undefined | Blog & Press - formation.bio
2023年12月5日 · Formation Bio (formerly known as TrialSpark) licenses sprifermin, an investigational first-in-class disease modifying treatment for osteoarthritis, from Merck KGaA, Darmstadt, Germany and announces formation of High Line Bio.
undefined | For Investigators - formation.bio
Reduce unnecessary work using Formation Bio resources designed specifically for sites. Our proprietary software enables sites to bypass manual EDC entry, and our in-house research nurses provide screening support to help you enroll as quickly as possible.